Phase 2 Prostate Adenocarcinoma trials recruiting now

All Prostate Adenocarcinoma trials, every phase

Other phases for Prostate Adenocarcinoma

Phase 2 Prostate Adenocarcinoma trials

• A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
  NCT05726292 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
  NCT07635238 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 7 locations
• A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
  NCT05751434 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 10 locations
• Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
  NCT07025369 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)
  NCT04704505 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
  NCT05806515 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 133 locations
• Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance
  NCT07285057 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
  NCT06330805 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
  NCT05616650 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: Male · 1 location
• Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial
  NCT06067269 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
  NCT03933670 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• INSPIRE: INnovative SABR for Prostate Cancer All IREland
  NCT07552168 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 4 locations
• Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
  NCT05832086 · Phase: Phase 2 · Ages: No age limits stated · Sex: Male · 3 locations
• Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
  NCT03821246 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
  NCT06798558 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 3 locations
• PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer
  NCT06392295 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial
  NCT06022822 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 5 locations
• Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
  NCT06957691 · Phase: Phase 2 · Ages: 40 Years and older · Sex: Male · 1 location
• Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study
  NCT04175431 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial
  NCT06499870 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer
  NCT06369610 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer
  NCT07364071 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)
  NCT06654336 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 3 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.